Title of article :
Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou
Author/Authors :
Li ، Yuping Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Tahamtani ، Yaser Department of Diabetes, Obesity and Metabolism, Department of Stem Cells and Developmental Biology - Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology - Academic Center for Education, Culture and Research (ACECR) , Totonchi ، Mehdi Department of Stem Cells and Developmental Biology, Department of Genetics - Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine - Academic Center for Education, Culture and Research (ACECR) , Chen ، Chengshui .Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Hashemian ، Mohammad Reza Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD) - Shahid Beheshti University of Medical Sciences , Amoozegar ، Fatemeh Noncommunicable diseases research center - Fasa University of Medical Sciences , Zhang ، Jin-San Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Gholampour ، Yousef Department of Internal Medicine - School of Medicine - Fasa University of Medical Sciences , Li ، Xiaokun Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University
Abstract :
The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)-scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.
Keywords :
Anti , inflammatory Drug , Antiviral Drug , COVID , 19 , Diagnosis , SARS , CoV , 2
Journal title :
Cell Journal (Yakhteh)
Journal title :
Cell Journal (Yakhteh)
